John P. Wareham, chairman of the STERIS board of directors, noted, "Under Les' leadership, many organizational and operational improvements have been made and new businesses and markets have been opened, which have positioned the company to take advantage of the many opportunities that exist for STERIS. We are very appreciative of Les' many contributions at STERIS and his continued willingness to support the company's objectives, and we wish him every future success and happiness."
The board has formed a search committee to implement the search process for a successor. Additionally, a transition committee appointed by the board and led by Wareham will work with Vinney during the transition process to facilitate a smooth transfer of responsibilities. Wareham further commented, "We expect our succession plan process will support STERIS's continuing efforts to build on its remarkable past and achieve even greater successes in the future."
Vinney commented, "It has been my distinct pleasure to serve STERIS in various leadership roles during a period that has positioned the company as a $1.2 billion global leader in the rapidly developing areas of infection control, decontamination and health sciences. I am proud of the many accomplishments achieved and the shareholder value created by my 5,000 STERIS colleagues over the past seven years. The company is now well positioned for a new leader to take it to new heights."
Vinney joined STERIS in August 1999 as senior vice president and chief financial officer, and was elected senior vice president of finance and operations in October 1999. He was named president and CEO in March 2000, and president and CEO in July
2000. Prior to joining STERIS, Vinney served as senior vice president and chief financial officer of the BF Goodrich Company.